These recommendations are based on the following:(1) a formal review and analysis of the
recently published world literature on the topic [Medline search up to June 2011];(2) the …

Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

Background Chronic hepatitis C virus (HCV) infection is more prevalent among patients who
have chronic kidney disease than among those who do not have the disease. Patients with …

Guidelines; 1 (3) guideline policies of the three societies approving this document; and (4)
the experience of the authors and independent reviewers with regards to NAFLD. Intended …

Introduction Recently, a study showed that Controlled Attenuation Parameter (CAP),
evaluated with transient elastography, could efficiently separate steatosis grades. The aim of …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …

The term non-alcoholic liver disease (NAFLD) was originally coined to describe hepatic fat
deposition as part of the metabolic syndrome. However, a variety of rare hereditary liver and …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of pathologies ranging
from uncomplicated hepatic fat accumulation to a state of lobular inflammation and …

Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

This study assessed the efficacy and safety of ribavirin‐free coformulated glecaprevir/
pibrentasvir (G/P) in patients with hepatitis C virus genotype 3 infection with prior treatment …